Over the past 12 months, 9 insiders at ABEONA THERAPEUTICS INC. filed 41 open-market SEC Form 4 transactions on ABEO: 0 purchases worth $0 and 41 sales worth $3.8M. Insiders have been net sellers over this period. The most recent filing was on Jul 21, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 21, 26 | Joseph Walter VazzanoChief Financial Officer | SELL | 1.5K | $6.53 | $10K |
| Jul 9, 26 | Brendan M. O'MalleySVP, Chief Legal Officer | SELL | 12.1K | $6.96 | $84K |
| Jul 9, 26 | Vishwas SeshadriChief Executive Officer | SELL | 68.0K | $6.96 | $473K |
| Jul 9, 26 | Madhav VasanthavadaChief Commercial Officer | SELL | 12.6K | $6.96 | $88K |
| Jul 9, 26 | Joseph Walter VazzanoChief Financial Officer | SELL | 24.9K | $6.96 | $173K |
| Jun 30, 26 | Leila Alland | SELL | 11.0K | $5.92 | $65K |
| Jun 15, 26 | Christine Berni Silverstein | SELL | 18.2K | $5.71 | $104K |
| Jun 9, 26 | Brendan M. O'MalleySVP, Chief Legal Officer | SELL | 6.3K | $5.30 | $33K |
| Jun 9, 26 | Vishwas SeshadriChief Executive Officer | SELL | 31.9K | $5.30 | $169K |
| Jun 9, 26 | Madhav VasanthavadaChief Commercial Officer | SELL | 5.5K | $5.30 | $29K |
| Jun 9, 26 | Joseph Walter VazzanoChief Financial Officer | SELL | 25.6K | $5.39 | $138K |
| Jun 8, 26 | Brendan M. O'MalleySVP, Chief Legal Officer | SELL | 4.8K | $5.43 | $26K |
| Jun 8, 26 | Vishwas SeshadriChief Executive Officer | SELL | 24.4K | $5.43 | $133K |
| Jun 8, 26 | Madhav VasanthavadaChief Commercial Officer | SELL | 4.2K | $5.43 | $23K |
| Jun 8, 26 | Joseph Walter VazzanoChief Financial Officer | SELL | 10.3K | $5.43 | $56K |
| May 22, 26 | Mark Alvino | SELL | 6.5K | $5.46 | $35K |
| May 15, 26 | Eric Crombez | SELL | 26.1K | $5.53 | $145K |
| May 11, 26 | Madhav VasanthavadaChief Commercial Officer | SELL | 5.5K | $5.96 | $33K |
| Mar 31, 26 | Vishwas SeshadriChief Executive Officer | SELL | 30.0K | $4.38 | $131K |
| Mar 16, 26 | Joseph Walter VazzanoChief Financial Officer | SELL | 785 | $4.76 | $4K |
| Feb 2, 26 | Leila AllandDirector | SELL | 18.1K | $5.09 | $92K |
| Feb 2, 26 | Mark AlvinoDirector | SELL | 2.0K | $5.09 | $10K |
| Feb 2, 26 | Eric CrombezDirector | SELL | 16.3K | $5.09 | $83K |
| Feb 2, 26 | Christine Berni SilversteinDirector | SELL | 20.1K | $5.09 | $102K |
| Feb 2, 26 | Donald A. WuchterlDirector | SELL | 14.8K | $5.09 | $75K |
| Jan 22, 26 | Brendan M. O'MalleySVP, Chief Legal Officer | SELL | 13.6K | $5.33 | $72K |
| Jan 22, 26 | Vishwas SeshadriChief Executive Officer | SELL | 69.8K | $5.33 | $372K |
| Jan 22, 26 | Joseph Walter VazzanoChief Financial Officer | SELL | 18.7K | $5.33 | $99K |
| Jan 22, 26 | Madhav VasanthavadaChief Commercial Officer | SELL | 12.6K | $5.29 | $67K |
| Jan 21, 26 | Mark AlvinoDirector | SELL | 13.5K | $5.23 | $71K |
| Dec 29, 25 | Vishwas SeshadriChief Executive Officer | SELL | 25.0K | $5.31 | $133K |
| Nov 13, 25 | Mark AlvinoDirector | SELL | 15.0K | $4.74 | $71K |
| Oct 16, 25 | Vishwas SeshadriChief Executive Officer | SELL | 249 | $5.49 | $1K |
| Sep 30, 25 | Vishwas SeshadriChief Executive Officer | SELL | 25.0K | $5.24 | $131K |
| Sep 29, 25 | Brendan M. O'MalleySVP, Chief Legal Officer | SELL | 9.4K | $5.39 | $50K |
| Sep 29, 25 | Vishwas SeshadriChief Executive Officer | SELL | 19.3K | $5.39 | $104K |
| Sep 29, 25 | Joseph Walter VazzanoChief Financial Officer | SELL | 9.0K | $5.39 | $49K |
| Sep 22, 25 | Brendan M. O'MalleySVP, Chief Legal Officer | SELL | 688 | $5.43 | $4K |
| Aug 15, 25 | Joseph Walter VazzanoChief Financial Officer | SELL | 15.0K | $7.36 | $110K |
| Aug 14, 25 | Eric CrombezDirector | SELL | 4.7K | $6.93 | $33K |
| Jul 22, 25 | Joseph Walter VazzanoChief Financial Officer | SELL | 1.5K | $6.64 | $10K |
| Jul 9, 25 | Mark AlvinoDirector | SELL | 13.1K | $5.86 | $77K |
| Jul 9, 25 | Faith L. CharlesDirector | SELL | 10.7K | $5.86 | $63K |
| Jul 9, 25 | Brendan M. O'MalleySVP, Chief Legal Officer | SELL | 17.4K | $5.86 | $102K |
| Jul 9, 25 | Vishwas SeshadriChief Executive Officer | SELL | 69.4K | $5.86 | $407K |
| Jul 9, 25 | Christine Berni SilversteinDirector | SELL | 13.1K | $5.86 | $77K |
| Jul 9, 25 | Joseph Walter VazzanoChief Financial Officer | SELL | 25.4K | $5.86 | $149K |
| Jul 8, 25 | Donald A. WuchterlDirector | SELL | 5.2K | $5.82 | $30K |
| Jun 6, 25 | Brendan M. O'MalleySVP, General Counsel | SELL | 10.5K | $6.76 | $71K |
| Jun 6, 25 | Vishwas SeshadriChief Executive Officer | SELL | 50.7K | $6.76 | $343K |
Over the past 12 months, insiders at ABEONA THERAPEUTICS INC. filed 0 open-market purchases worth $0 and 41 sales worth $3.8M on ABEO, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 21, 26.
9 different insiders at ABEONA THERAPEUTICS INC. filed open-market SEC Form 4 transactions on ABEO over the last 12 months.
InsiderTape plots every ABEO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ABEONA THERAPEUTICS INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →